The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
about
A randomized pilot study of atractylenolide I on gastric cancer cachexia patientsFibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trialDistinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Managing Patients With Myelofibrosis in the Era of Janus Kinase InhibitorsCorticotropin-releasing hormone regulates IL-6 expression during inflammationCancer cachexia: impact, mechanisms and emerging treatmentsDistinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.Inflammation based regulation of cancer cachexiaPredictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma.Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling.Hypothalamic mechanisms in cachexia.The therapeutic potential of interleukin-6 hyperagonists and antagonists.A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.The use of melanocortin antagonists in cachexia of chronic disease.Cancer cachexia, mechanism and treatmentPathophysiology and treatment of inflammatory anorexia in chronic disease.Interleukin 6 as a key regulator of muscle mass during cachexiaStructural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis.Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells.Mechanisms of Cachexia in Chronic Disease StatesJAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patientsEnergy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study.Pretreatment serum markers and lymphocyte response to interleukin-2 therapyThe systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.Angiogenesis is an independent prognostic factor in malignant mesothelioma.Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancerThe response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing patients with pancreatic cancerThe relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.Interleukin-6 and its receptor in cancer: implications for translational therapeutics.Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia.Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wastingEffect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice.New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line.Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers.Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.Functional and Morphological Improvement of Dystrophic Muscle by Interleukin 6 Receptor Blockade.
P2860
Q24654205-D85BA935-D16A-4B59-9059-019527951A23Q24807379-25AA566D-CF9A-419C-BA42-4444DC8F7642Q24810591-1178E4BC-A33D-47EA-A6A7-38009B888324Q28068034-90ED13EE-3289-4A34-A99F-14A5F5A14EACQ28073296-4206223E-8FEC-4019-B060-953C8C9C1FFEQ28361834-155813C9-344B-498B-ACA6-26FBF83B296DQ28384479-3C0BC970-24A5-4DB9-A347-B727726658F9Q28542391-C71966DF-A43D-4F75-9B11-98223737BFE4Q31028277-2DDC0A9F-42D3-40BD-A1B8-6B6E6886B164Q33615916-F1920790-F327-4F3C-B2A8-61030616FB3CQ33684941-319EDEE0-379D-4775-AF99-5BC85368DB82Q33700636-D126E25C-493E-42E1-979D-554F9CB83297Q34081332-892EAD30-CBC9-43B3-882A-A04FAE55100EQ34430168-F1ED7E1D-F2BD-4569-9DBE-BC77DDF18EB4Q34502402-C9170ABB-9E33-48D9-B8B0-604A845E4376Q34561151-61A1770D-19F3-4A9A-8038-ED153A1A7021Q34669440-2DB0718C-28DE-4BD1-83AE-7AFB06C194E6Q34697279-F21DA541-44C9-44C9-8F93-9F7D541C56C1Q34727530-39D4E5BE-380B-4991-8B8B-0861BF05461DQ35728036-E020E182-DFA2-4646-87FF-EDF05479E122Q35844693-4D030A10-A7F9-489B-9D0E-855BAF0C7C91Q36103986-1BEE72D7-6AFF-4F61-A798-718EE6E76BC7Q36176015-BDC9FCF2-CD00-45FE-9845-F279436B6863Q36431112-10592891-4C4E-48EB-BCF9-1C16FAD36A5BQ36616257-67AC2581-D0A6-42F8-8130-5BDE852C21D2Q36617894-B23483AF-EF9B-49F5-ACBC-75CCED5AC918Q36623998-B63ECAE4-122A-4341-AD7A-D5FF62C6EC82Q36643416-AAD86D85-3544-448D-8B73-01C2996EBE9AQ36648454-0B58068B-124B-4AD5-A6AA-A6EDCA1FE053Q36694785-12E7D1E4-EBA1-439F-88FA-719F5A79599EQ36696573-53F967E9-7D25-4BFD-95D8-7D91AB920CA5Q36938072-5A3A1A5F-E27E-4787-8EF0-139B58C77648Q37924325-8CA9D00C-83AE-41F4-8A45-FA57749478EBQ38434245-45DA79E1-D697-44CE-8945-7A49B4A73F1FQ38981451-2912CE1B-4297-4760-A79D-29B6DDB69B04Q39042463-810C4A0E-7933-4574-9340-F7C02FD84C12Q39154321-5E063602-0664-4E7B-8528-B3025D0D037DQ39745261-004B87EC-A39A-4D6B-8D54-5A95A47D32E3Q40433122-5CE70057-C65A-4D63-AD87-DCB1673B5CF6Q40773636-3DF4D265-F311-49DE-B9D5-C9DF090FF670
P2860
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
@ast
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
@en
type
label
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
@ast
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
@en
prefLabel
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
@ast
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
@en
P2093
P2860
P356
P1476
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.294
P407
P577
1996-06-01T00:00:00Z
P5875
P6179
1016330939